ZYH Biotech focuses on the development of biopharmaceuticals for diabetes, using gene engineering methods to produce GLP-1 and insulin-based biopharmaceuticals, and exploring new drugs and treatments for diabetes.

Exploring unique solutions for Diabetes biopharmaceuticals

Based on more than 20 years experience of enetic engineering, product standardization, operational standardization, and quality management standardization,we can offer whole set of solution for customers needing develop new ingredients or wanting cost reducing especially in optimizing protein products

We are at the forefront of 

Custom ingredients from gene synthesis to commercial quantity production